Heiner Pieper

Heiner graduated in Economics and Business Administration from the University of Cologne, and started his pharmaceutical career at Bayer. His experience spans over 25 years in commercial functions in Europe and Latin America. He has also worked for ASTA Medica AG and Baxter as country manager in Argentina and regional director for Latin America where he led Oncology for key brands such as Navelbine® and Holoxan®. In 2003, he joined Merck KGaA’s headquarters in Darmstadt, where he became the regional director for Latin America and launched Erbitux® within the Oncology franchise. With the acquisition of Serono in 2007 he moved to business development in Geneva and headed MerckSerono’s global department for emerging markets and general medicine before joining PharmaMar in 2013 as VP, BD&L. He is a member of the Pharmaceutical Licensing Club in Germany (PLCD) and part of the European network of Pharmaceutical Licensing groups (EPLG).